• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Fitbit, Fitabase Reaches Over 200 Clinical Studies to Date MIlestone

by HITC Staff 08/01/2016 Leave a Comment

Fitbit_Blaze_Lineup

Fitabase, a research platform that collects data from internet-connected devices and wearable fitness maker Fitbit announced that it has completed over 200+ clinical studies to incorporate activity, sleep, and heart rate data. Some of the leading research institutions include Johns Hopkins University, Northwestern University, the University of Texas MD Anderson Cancer Center, and the University of California San Diego. 

Over the last four years, Fitbit and Fitabase have helped researchers continuously and objectively measure physical activity, engage patients in a new way, and enable just-in-time adaptive interventions. To date, Fitabase has collected over 2 billion minutes of Fitbit data on behalf of their research customers.

Fitbit and Fitabase Are Used to Continuously, Objectively Measure Physical Activity

Researchers often rely on self-reported data, which are subject to recall bias and other measurement error – especially as related to physical activity and sleep. While data from the National Health and Examination Survey (NHANES) showed that 62 percent of Americans reported meeting the Physical Activity Guidelines for Americans, objective accelerometer data showed that less than 10 percent of Americans actually met the guidelines.[1] Fitbit can help close that gap. A recent validation study that used the Fitabase platform was published in the International Journal of Cardiology and concluded that Fitbit trackers may be  “an accurate, reliable, and efficient tool for physicians to track the adoption/maintenance of physical activity programs and support their patient’s attempt at an active lifestyle.”[2]

This is why investigators from Northwestern Medicine and the University of California San Francisco collaborated with Fitbit and Fitabase to conduct a joint study on minimally invasive spine surgeries for degenerative disease and deformity, such as correcting scoliosis. In an effort to better predict recovery over time for patients who undergo spine surgery, the researchers are monitoring physical activity using Fitbit trackers.

During the four weeks before surgery and for six months afterward, Fitbit devices will capture personal data on a patient’s steps and activity levels. If successful, physicians may be able to use a physical activity monitoring approach to predict which patients are at risk of hospital readmission.

 



[1] http://www.ncbi.nlm.nih.gov/pubmed/21406280

[2] http://www.internationaljournalofcardiology.com/article/S0167-5273(15)00276-4/abstract

Tagged With: Clinical Trails, Fitabase, Fitbit

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |